COEXISTENCE OF GLUCOCORTICOID RECEPTOR AND PHARMACOKINETIC ABNORMALITIES - FACTORS THAT CONTRIBUTE TO A POOR RESPONSE TO TREATMENT WITH GLUCOCORTICOIDS IN CHILDREN WITH ASTHMA

被引:21
作者
KAMADA, AK
SPAHN, JD
SURS, W
BROWN, E
LEUNG, DYM
SZEFLER, SJ
机构
[1] NATL JEWISH CTR IMMUNOL & RESP MED, DEPT PEDIAT, DIV CLIN PHARMACOL, DENVER, CO 80206 USA
[2] NATL JEWISH CTR IMMUNOL & RESP MED, DEPT MED, DIV CLIN PHARMACOL, DENVER, CO 80206 USA
[3] NATL JEWISH CTR IMMUNOL & RESP MED, DEPT PEDIAT, DIV ALLERGY CLIN IMMUNOL, DENVER, CO 80206 USA
[4] NATL JEWISH CTR IMMUNOL & RESP MED, DEPT MED, DIV ALLERGY CLIN IMMUNOL, DENVER, CO 80206 USA
[5] UNIV COLORADO, HLTH SCI CTR, DEPT PEDIAT, DENVER, CO 80262 USA
[6] UNIV COLORADO, HLTH SCI CTR, DEPT PHARMACOL, DENVER, CO 80262 USA
关键词
D O I
10.1016/S0022-3476(05)83198-1
中图分类号
R72 [儿科学];
学科分类号
100202 [儿科学];
摘要
Rapid glucocorticoid clearance and abnormal glucocorticoid receptor binding have been described as factors that contribute to an inadequate response to treatment with glucocorticoids in patients with asthma. We report the coexistence of these abnormalities in children with severe asthma who respond poorly to systemic glucocorticoid therapy.
引用
收藏
页码:984 / 986
页数:3
相关论文
共 9 条
[1]
STEROID-RESISTANT ASTHMA - IMMUNOLOGICAL AND PHARMACOLOGICAL FEATURES [J].
ALVAREZ, J ;
SURS, W ;
LEUNG, DYM ;
IKLE, D ;
GELFAND, EW ;
SZEFLER, SJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (03) :714-721
[2]
PREDNISOLONE AND METHYLPREDNISOLONE KINETICS IN CHILDREN RECEIVING ANTICONVULSANT THERAPY [J].
BARTOSZEK, M ;
BRENNER, AM ;
SZEFLER, SJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (04) :424-432
[3]
GLUCOCORTICOID RESISTANCE IN CHRONIC ASTHMA - GLUCOCORTICOID PHARMACOKINETICS, GLUCOCORTICOID RECEPTOR CHARACTERISTICS, AND INHIBITION OF PERIPHERAL-BLOOD T-CELL PROLIFERATION BY GLUCOCORTICOIDS INVITRO [J].
CORRIGAN, CJ ;
BROWN, PH ;
BARNES, NC ;
SZEFLER, SJ ;
TSAI, JJ ;
FREW, AJ ;
KAY, AB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05) :1016-1025
[4]
CRABTREE GR, 1981, METHODS HEMATOLOGY, V2, P252
[5]
MONITORING GLUCOCORTICOID THERAPY - A PHARMACOKINETIC APPROACH [J].
HILL, MR ;
SZEFLER, SJ ;
BALL, BD ;
BARTOSZEK, M ;
BRENNER, AM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (04) :390-398
[6]
DIFFICULT-TO-CONTROL ASTHMA - CONTRIBUTING FACTORS AND OUTCOME OF A SYSTEMATIC MANAGEMENT PROTOCOL [J].
IRWIN, RS ;
CURLEY, FJ ;
FRENCH, CL .
CHEST, 1993, 103 (06) :1662-1669
[7]
KAM JC, 1993, J IMMUNOL, V151, P3460
[8]
HIGH-DOSE SYSTEMIC GLUCOCORTICOID THERAPY IN THE TREATMENT OF SEVERE ASTHMA - A CASE OF RESISTANCE AND PATTERNS OF RESPONSE [J].
KAMADA, AK ;
LEUNG, DYM ;
GLEASON, MC ;
HILL, MR ;
SZEFLER, SJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 90 (04) :685-687
[9]
STEROID-RESISTANT ASTHMA - CELLULAR MECHANISMS CONTRIBUTING TO INADEQUATE RESPONSE TO GLUCOCORTICOID THERAPY [J].
SHER, ER ;
LEUNG, DYM ;
SURS, W ;
KAM, JC ;
ZIEG, G ;
KAMADA, AK ;
SZEFLER, SJ .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) :33-39